Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: A 78-week randomized, doubleblind, placebo-controlled trial - Rosenstock, J; Jelaska, A; Zeller, C (Diabetes Obesity Metab, 2015)
et al.